BBS1 Antibody / Bardet-Biedl syndrome 1, 100 ug

The BBS1 antibody targets Bardet-Biedl syndrome 1 protein, a centrosomal and ciliary component encoded by the BBS1 gene. This protein is a core subunit of the BBSome, a multimeric complex required for the trafficking of membrane proteins to and from primary cilia. Bardet-Biedl syndrome 1 protein plays a crucial role in ciliary signaling, cell polarity, and sensory perception. The BBS1 antibody provides a key reagent for studying cilia function, intracellular transport, and ciliopathies associated with BBSome dysfunction.

The BBSome complex, composed of at least eight core proteins including BBS1, BBS2, BBS4, and BBS7, mediates cargo recognition and vesicular transport along the ciliary membrane. Bardet-Biedl syndrome 1 protein acts as a structural hub that anchors the complex to the basal body and interacts with small GTPases such as ARL6. The BBS1 antibody allows visualization of this component in centrosomes and cilia, supporting studies into how BBSome assembly regulates signaling receptor localization and function.

Mutations in BBS1 are the most common cause of Bardet-Biedl syndrome, a pleiotropic ciliopathy characterized by retinal degeneration, obesity, renal anomalies, and polydactyly. These mutations impair BBSome stability and disrupt ciliary transport of G-protein-coupled receptors (GPCRs). The BBS1 antibody supports functional research into these mechanisms by enabling analysis of protein expression, localization, and complex formation in patient cells and model organisms. It is a critical tool for defining how ciliary trafficking defects lead to multisystemic disease manifestations.

Beyond ciliopathy research, Bardet-Biedl syndrome 1 protein has been implicated in metabolic regulation, immune signaling, and neural development. The BBS1 antibody supports studies exploring these expanded roles, including how BBSome components modulate leptin receptor and Hedgehog signaling pathways. Dysregulation of ciliary protein transport impacts sensory and hormonal signaling, linking BBS1 to diverse physiological processes.

The BBS1 antibody performs effectively in western blotting, immunofluorescence, and immunohistochemistry, revealing punctate centrosomal and ciliary staining patterns. NSJ Bioreagents provides this antibody with validated specificity for reproducible detection across mammalian models. By enabling precise analysis of Bardet-Biedl syndrome 1 protein, the BBS1 antibody supports ongoing research into ciliary trafficking, BBSome structure, and the molecular basis of human ciliopathies.